|
| |
Image Results
Loading...
Loading...
Genvec PEDF Viral Pages on BioPortfolio:
|
BioPortfolio News: GenVec, Inc. - FDA Grants Orphan Drug ...
GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs ... GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical ...
http://www.bioportfolio.com/news/FDA-Grants-Orphan-Drug-Desi...
|
BioPortfolio News: GenVec, Inc. - GenVec Reports Third Quarter 2009...
6 Nov 2009 ... GenVec was awarded a SBIR grant, valued at approximately $300000, from the National .... Browse news from 2009 · Download PDF PDF Version ...
http://www.bioportfolio.com/news/GenVec-Reports-Third-Quarte...
|
BioPortfolio News: GenVec, Inc. - GenVec Signs New Contract to ...
Over the next year, GenVec will receive approximately $2.6 million. ... GenVec also uses its proprietary adenovector technology to develop vaccines for ...
http://www.bioportfolio.com/news/GenVec-Signs-New-Contract-t...
|
BioPortfolio - SAIC - Profile
*Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center,- J Leukoc ... signed a contract with GenVec for the development of influenza and HIV ...
http://www.bioportfolio.com/biocorporate/9108-SAIC.pdf...
|
BioPortfolio - National Institute of Allergy
Identification of viral microRNAs expressed in human sacral ganglia latently infected ... GenVec Signs New Contract to Support HIV and Influenza Vaccine ...
http://www.bioportfolio.com/biocorporate/7375-National_Insti...
|
BioPortfolio - GenVec, Inc. - GenVec Receives National Cancer ...
GenVec, Inc. - GenVec Receives National Cancer Institute Grant to Expand Cancer ... Under this grant, valued at over $300000, GenVec will investigate the ...
http://www.bioportfolio.com/news/GenVec_Receives_National_Ca...
|
BioPortfolio News: GenVec, Inc. - GenVec Announces Third Quarter ...
GenVec will hold a conference call at 10:00 a.m. EST on Friday, November 6, 2009 to discuss ... To access the webcast or the replay, go to www.genvec.com, ...
http://www.bioportfolio.com/news/GenVec-Announces-Third-Quar...
| Results from other life science and pharmaceutical sites:
Support to Ukraine in Implementing Its National TB Program
GenVec's technology modifies the adenovirus—a common cold virus—so that it can't ... GenVec's adenovector technology has the potential to increase the ...
http://www.malariavaccine.org/files/GenVec_FS.pdf...
|
Molecular Therapy - Abstract of article: 57. Persistent PEDF ...
1Research, GenVec, Gaithersburg, MD; 2Ophthalmology, Johns Hopkins University, Baltimore, ... PEDF vector preparations containing less than 0.05% helper virus
... cassette located at the left end of the viral chromosome adjacent to the ...
http://www.nature.com/mt/journal/v9/n1s/abs/mt2004181a.html...
|
Alternate serotype adenovector provides long-term therapeutic gene ...
On Day 0, mice received one IVT injection of Ad5.PEDF or Ad35.PEDF (HI-RGD) .... luciferase or PEDF were constructed using GenVec's AdFAST technology, ... number
of viral particle units (1×109 pu) upon depression of a foot switch. ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613074/...
|
Phase 1 macular degeneration study shows encouraging results ...
The study's sponsor, GenVec Inc., produced AdPEDF by combining the PEDF gene with an inactivated virus, known as a vector, which is commonly used in ...
http://www.bcm.edu/fromthelab/vol04/is1/05feb_n3.htm...
|
Targeted adenovirus-mediated gene delivery to T cells via CD3.
GenVec, Inc., Rockville, Maryland 20852-1709, USA. wickham@genvec.com ... The Full Text of this article is available as a PDF (185K). .... VAI RNA is required
for efficient translation of viral mRNAs at late times after infection. Cell.
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC192116/...
|
Foot-and-Mouth Disease
GenVec, Inc., a biopharmaceutical com- pany based in Gaithersburg, ... ARS and GenVec are now collaborating to combine the interferons and the FMD ...
http://www.ars.usda.gov/is/ar/archive/apr09/disease0409.pdf...
|
Expression of gp19K increases the persistence of transgene ...
GenVec, Inc., Rockville, Maryland 20852, USA. bruder@genvec.com ... The Full Text of this article is available as a PDF (669K). ... Recombinant adenovirus
deleted of all viral genes for gene therapy of cystic fibrosis. Virology. ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC192111/...
|
The role of receptors in the maturation-dependent adenoviral ...
Table of contents Previous Abstract Next Full text PDF ... 3 Genvec, Inc., Gaithersburg, MD, USA. 4Department of Immunogenetics, Children's Hospital of ...
It was recently proposed that the viral receptors (Coxsackie and adenovirus ...
http://www.nature.com/gt/journal/v8/n8/abs/3301425a.html...
|
A gene transfer vector-cell line system for complete functional ...
GenVec Inc., Rockville, Maryland 20852, USA. ... The Full Text of this article is available as a PDF (375K). ... Multiple functions of the adenovirus DNA-
binding protein are required for efficient viral DNA synthesis. Virology. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=19...
|
Activation of transgene expression by early region 4 is ...
GenVec Inc., Rockville, Maryland 20852, USA. brough@genvec.com. Small right arrow pointing to: ... The Full Text of this article is available as a PDF (966K
). ... Persistence in muscle of an adenoviral vector that lacks all viral genes.
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC230223/...
|
|
